Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Neuphoria Therapeutics Inc. (NEUP)

Cocrystal Pharma, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. is the larger, with a market value of $19.8M against $17.9M — 1.1× the size. Neuphoria Therapeutics Inc. grew revenue faster over the last twelve months: 3,535.1% against −30.4%. Neuphoria Therapeutics Inc. has the higher net margin (0.00% vs −747.8%) and the lower return on invested capital (−232.7% vs 0.00%). Across the 17 metrics below, Neuphoria Therapeutics Inc. leads on 11 and Cocrystal Pharma, Inc. on 6.

Valuation

Metric COCP NEUP Biotechnology median
P/E n/m n/m 8.50
P/S 10.58 0.91 9.71
P/B 13.47 0.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.27 0.64
EV/Sales 8.90 (0.30) 9.21
Earnings yield (74.51%) (154.60%) (33.15%)
Free cash flow yield (56.64%) (85.14%) (25.50%)

Profitability

Metric COCP NEUP Biotechnology median
Gross margin 9.10% 0.00% 65.16%
Operating margin (760.72%) 0.00% 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) (61.70%) (56.36%)
Return on assets (151.10%) (46.95%) (48.04%)
Return on invested capital 0.00% (232.67%) 0.00%

Growth

Metric COCP NEUP Biotechnology median
Revenue growth (TTM) (30.38%) 3,535.05% 6.02%
EPS growth (last fiscal year) 54.65% (1,230.43%) 30.26%
Revenue growth, 5-year CAGR (33.30%) 19.07% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP NEUP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 27.85 4.72
Net debt to EBITDA 0.82 1.26 0.96

Dividend

Metric COCP NEUP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COCP NEUP Biotechnology median
Market cap 19.84m 17.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack